MedPath

LungSMART Trial Aims to Boost Lung Cancer Screening via Telehealth in Community Health Centers

• LungSMART, supported by the NCI, joins the NIH Pragmatic Trials Collaboratory to improve lung cancer screening rates. • The trial will implement telehealth interventions in Utah community health centers to overcome logistical barriers and hesitancy. • LungSMART employs a sequential multiple-assignment randomized trial (SMART) design to optimize intervention strategies. • The project addresses disparities in lung cancer screening related to race/ethnicity and socioeconomic status.

Lung cancer screening rates are notably low, with only 6.5% of eligible individuals screened in 2020, prompting the launch of the LungSMART trial. This initiative seeks to increase these rates through telehealth interventions within community health centers, particularly focusing on addressing disparities related to race/ethnicity and socioeconomic status.

Addressing Screening Disparities

LungSMART (Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers) will employ a sequential multiple-assignment randomized trial (SMART) design. This approach allows researchers to test and adapt telehealth interventions to best suit the needs of individuals hesitant about or facing logistical barriers to lung cancer screening.
The trial is being conducted in community health centers throughout Utah, with the goal of creating a scalable model for other regions.

Leadership and Support

David Wetter, Guilherme Del Fiol, and Ken Kawamoto from the University of Utah serve as the principal investigators for LungSMART. The project is supported by a grant from the National Cancer Institute (NCI), marking a significant milestone as the first NCI-supported trial within the NIH Pragmatic Trials Collaboratory.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

STEP-2 Trial of Cervical Cancer Screening Interventions Joins the NIH Collaboratory

The NIH Pragmatic Trials Collaboratory welcomes the STEP-2 trial, focusing on cervical cancer screening through self-sampling kits in underserved populations, to its portfolio. This trial aims to address the low screening rates exacerbated by the COVID-19 pandemic by evaluating the effectiveness of different distribution methods of HPV self-sampling kits.

BerGenBio's Bemcentinib Enters Clinical Trial for Advanced Lung Adenocarcinoma

BerGenBio's bemcentinib is being evaluated in a Phase Ib/II clinical trial in combination with pacritinib for advanced lung adenocarcinoma.
The trial, sponsored by the Mays Cancer Center, aims to address unmet needs in lung cancer treatment by targeting AXL and JAK-STAT3 pathways.

AI Chatbot Trial Aims to Boost Cervical Cancer Screening Participation

An IARC-led randomized controlled trial is evaluating an AI-powered chatbot to increase cervical cancer screening among women.
The chatbot provides a multi-language decision aid accessible via smartphones, focusing on women with lower education and from disadvantaged areas.

NIH Pragmatic Trials Collaboratory Highlights Innovations and Insights from 2024

The NIH Pragmatic Trials Collaboratory published results from completed studies and shared insights into pragmatic clinical trial design and analysis.
In 2024, the program contributed over 30 articles to peer-reviewed literature, including primary results from the ICD-Pieces and Nudge trials.

NIH's TrialGPT AI Algorithm Streamlines Clinical Trial Matching

The NIH has developed TrialGPT, an AI algorithm designed to efficiently match patients to relevant clinical trials listed on ClinicalTrials.gov.
TrialGPT demonstrated accuracy comparable to human clinicians in assessing eligibility criteria, while reducing screening time by 40% in a pilot study.

NIH Collaboratory Adds APA-SM Trial to Evaluate Acupressure for Chronic Pain Management

The NIH Pragmatic Trials Collaboratory welcomes the APA-SM trial, focusing on personalized auricular point acupressure for chronic pain self-management in rural areas.
The APA-SM trial will conduct a pragmatic study of a 4-week auricular point acupressure intervention in rural Texas and South Carolina.

$22 Million Boost for Australian Cancer Clinical Trials to Enhance Research and Access

Australia's cancer clinical trials receive a $22.19 million funding boost to support 14 multi-site Collaborative Cancer Clinical Trials Groups (CTGs) nationwide.
The funding, administered by Cancer Australia, aims to improve clinical trial design, enhance equitable access, and accelerate research translation into clinical practice.

HARMONIE Trial Reimagines Commercial Clinical Trial Design with Nirsevimab

The HARMONIE trial investigated the impact of nirsevimab on hospitalizations related to respiratory syncytial virus (RSV) in infants.
Conducted across France, Germany, and the UK, the trial adopted a pragmatic approach to assess nirsevimab's effectiveness.

NIH HEAL Initiative Funds Pragmatic Trials for Non-Opioid Pain Management

The NIH HEAL Initiative is funding pragmatic clinical trials focused on non-opioid pain management within the NIH-DOD-VA Pain Management Collaboratory.
The trials will study non-opioid approaches, including complementary and integrative methods, for managing pain and comorbid conditions in veterans and military personnel.

National Cancer Center to Initiate Basket Trial of BNCT for Thoracic Malignancies

The National Cancer Center Japan will conduct a Phase I/II basket trial of Boron Neutron Capture Therapy (BNCT) for unresectable and recurrent thoracic malignant solid tumors.
This trial is the first of its kind to evaluate BNCT across multiple thoracic cancer types, aiming to expedite development by grouping cancers with shared organs at risk.

Reference News

[1]
December 2, 2024: NCI-Supported LungSMART Trial Joins the NIH Pragmatic Trials Collaboratory
rethinkingclinicaltrials.org · Dec 2, 2024

NIH Pragmatic Trials Collaboratory adds LungSMART, a trial addressing lung cancer screening disparities in community hea...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy